Melatonin Tolerance and Dependence: What the Evidence Says About Nightly Use
Melatonin Tolerance and Dependence: What the Evidence Says About Nightly Use
Melatonin is not considered physically addictive, and there is little evidence of true pharmacological tolerance. But "it stopped working" and "I sleep worse when I skip it" are both common, and they usually have other explanations. A 2011 open-label study of 6 to 12 months of prolonged-release melatonin found no rebound or withdrawal. Cleveland Clinic's Dr. Marri Horvat says there is no need to wean off it. Stanford's Dr. Jamie Zeitzer says you can become psychologically dependent on it. Long-term safety data, meanwhile, is thin and the newest headlines are worrying but preliminary.
By Chester Takau · November 2026
Is melatonin addictive?
Not in the way people mean when they use that word. A viral TikTok claim called it "highly addictive" and drew a doctor's rebuttal in UK press coverage. The expert consensus I found is that melatonin does not cause cravings, escalating physical dependence or a benzodiazepine-style withdrawal syndrome. Zeitzer, via Rise Science, puts the caveat plainly: it "isn't addictive, but you can become psychologically dependent on it." Believing you cannot sleep without a pill can make sleep harder, whatever is in the pill.
I found no new 2026 study specifically on melatonin tolerance, withdrawal or tapering. The best-cited evidence is older, so treat the confident-sounding expert statements as informed opinion on a thin research base.
Why does melatonin seem to stop working?
Forum threads repeat the same stories: it worked for a couple of years and then quit, or "you quickly build up a tolerance." Experts generally put these down to causes other than true tolerance. The table below sorts the four most likely explanations. It is my synthesis of the sources, not a clinical tool.
"It stopped working": four explanations compared
| Explanation | What it looks like | Evidence |
|---|---|---|
| True tolerance | Same dose, same timing, steadily weaker effect | Little. The 2011 long-term study reported no loss of effect or rebound over 6–12 months |
| Wrong dose or timing | Taken at bedtime, or at 5–10 mg, expecting a sedative effect | Common. Cleveland Clinic suggests 1–3 mg, 1–2 hours before bed |
| Label variance | Results differ between bottles or brands | Real. A JAMA analysis found content from 74% to 347% of the label; Cleveland Clinic cites 80–400% |
| Insomnia returning, or psychological dependence | Worse sleep after skipping a night, worry about going without | Plausible. Experts attribute it to the original sleep problem or to habit, not withdrawal |
The "dosing artifact" idea is worth sitting with. Some commenters argue 0.3–1 mg is enough and that standard 3–10 mg pills are too much; that is a debate, not settled fact. But if a bottle can hold anywhere from three-quarters to more than three times its label, a "tolerance" story built on one bottle can be a different dose every month. UCLA Health's advice (June 2026) is the smallest effective dose, short term and as needed, in "USP Verified" products.
Timing and expectations matter too. Sleep physician Dr. Emma Lin told VICE that melatonin "doesn't directly sedate patients" and instead acts on circadian rhythm, and Dr. Michael Breus calls it a sleep regulator, not a sleep initiator. Treating it like a sedative, then raising the dose when it disappoints, is a recipe for the "tolerance" reports. The same timing logic is why it is better evidenced for travel; see melatonin for jet lag and how timing changes the result.
Does taking melatonin shut down my own production?
Cleveland Clinic says there is no evidence it suppresses the body's own production, and the 2011 open-label study of prolonged-release melatonin reached a similar conclusion over 6 to 12 months. That study was open-label, with no placebo group, so it can't rule out subtle effects. It is also much shorter than the years of nightly use many people report.
What does the heart-failure study mean for nightly users?
This is the finding that sent people searching. ScienceAlert (Oct 2026) reported on a study of more than 130,000 adults with insomnia. Those prescribed melatonin for over a year had a higher five-year risk of heart failure: 4.6% against 2.7%, an 89% relative increase but roughly one extra case per 53 long-term users. They were also about twice as likely to die from any cause (7.8% vs 4.3%) and about 3.5 times as likely to be hospitalized for heart failure. Saudi Arabia's drug regulator issued a safety signal in April 2026, calling the evidence "suggestive for causal association."
The limits are large. The work was presented at the AHA Scientific Sessions in November 2025 and is not peer-reviewed. It is observational, and melatonin use was estimated from prescription records, so people buying it over the counter may sit in the comparison group. UCLA Health's coverage notes critics' concern that confounders such as mental health and obesity were not adjusted for. The study does not show that melatonin causes heart failure, and it says nothing about tolerance. If you have taken it nightly for years, the sensible step is to raise it with your doctor, not to quit overnight in a panic.
For balance, an ASA review at ANESTHESIOLOGY 2026 of 16 studies and more than 1,100 surgical patients linked 1–20 mg to less anxiety, pain and inflammation. It is also a conference presentation, not a full paper. Most trials last under 7 days, so what happens after years of use is a real gap.
What does one expert say about physical dependence?
A guest neuroscientist on Thomas DeLauer's channel addresses the question directly. Two cautions: the video is reported by third-party listings to be a paid brand partnership, and DeLauer is not a clinician. The quote comes from an auto-generated transcript with no speaker labels, so I could not verify the guest's name.
"I've never seen any data to indicate that there's any physical dependence on melatonin that I'm aware of."
That matches the mainstream view, though "never seen data" is not the same as "data shows none," and the long-term data gap applies here too.
How do I stop taking melatonin after years of nightly use?
Experts say you don't need to taper, yet forum threads about getting off melatonin keep appearing, and people who skip one night after months of use report sleeping worse. Both can be true: the physical risk is low, and the habit is still hard to break. I found no trial of a tapering protocol, so the following is an illustration of the gentle step-down idea, not a tested schedule:
- Move to the lowest effective dose first, for example from 3 mg to 1 mg, and then lower still, such as 0.5 mg.
- Move to every other night once the lower dose feels uneventful, then to as-needed use.
- Keep bedtime, wake time and light exposure steady. CBT-I habits are the best-supported long-term fix for insomnia.
- Expect a few poor nights. Sleeping badly after stopping is more likely your original insomnia returning than withdrawal.
If you take other medicines, are pregnant, or have a heart condition, ask a doctor or pharmacist before changing anything. The MGH Center for Women's Mental Health published a pregnancy update in October 2026; I did not verify its conclusions, so check it directly.
What about herbal alternatives when coming off it?
This is where I'd like to hand you a ranked list, and I can't. I found no good evidence-graded comparison of tart cherry, magnesium, valerian, chamomile and glycine for people stepping down from melatonin, and none of them is free of its own cautions. The chamomile compound is one example worth reading about on its own: what apigenin is and how chamomile's calming compound works covers what is and isn't proven. Swapping one nightly crutch for another does not address the habit itself.
Quick answers
Should I skip nights so it keeps working? There is no evidence this prevents tolerance. If you only need it sometimes, use it as needed.
Is 3 mg too much? Cleveland Clinic recommends 1–3 mg, 1–2 hours before bed. Some argue lower is enough. Verify the product, because the label may be off by a wide margin.
Will I get withdrawal? Experts say no physical withdrawal syndrome. Poor sleep after stopping is common and usually temporary or from the underlying insomnia.
Sources
- ScienceAlert, Oct 2026: melatonin and heart failure, absolute risks, Saudi safety signal
- UCLA Health, Jun 2026: study caveats, label accuracy, dosing advice
- ASA, Oct 2026: melatonin before surgery review
- Cleveland Clinic: melatonin dependency (2022)
- 2011 open-label long-term study of prolonged-release melatonin
- Examine: melatonin toxicity, tolerance and addiction
- Rise Science: is melatonin addictive?
- Tom's Guide: Dr. Michael Breus on melatonin
- AnandTech forum thread: does melatonin work well for insomnia?
- Thomas DeLauer (sponsored): This Neuroscientist Just Changed Melatonin Forever
Updated November 2026.
Transparency note: This article was researched and written by Chester Takau with AI assistance for research gathering and drafting. All recommendations reflect the author's own editorial judgment.
